295 related articles for article (PubMed ID: 9300242)
21. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells.
Prins BA; Hu RM; Nazario B; Pedram A; Frank HJ; Weber MA; Levin ER
J Biol Chem; 1994 Apr; 269(16):11938-44. PubMed ID: 8163494
[TBL] [Abstract][Full Text] [Related]
22. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.
Hayashi S; Morishita R; Matsushita H; Nakagami H; Taniyama Y; Nakamura T; Aoki M; Yamamoto K; Higaki J; Ogihara T
Hypertension; 2000 Jan; 35(1 Pt 2):237-43. PubMed ID: 10642304
[TBL] [Abstract][Full Text] [Related]
23. Glucose inhibits prostacyclin production by cultured aortic endothelial cells.
Ono H; Umeda F; Inoguchi T; Ibayashi H
Thromb Haemost; 1988 Oct; 60(2):174-7. PubMed ID: 3064357
[TBL] [Abstract][Full Text] [Related]
24. Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes.
Suzuki K; Uchida K; Nakanishi N; Hattori Y
Am J Hypertens; 2008 Apr; 21(4):451-7. PubMed ID: 18369362
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF.
Michiels C; De Leener F; Arnould T; Dieu M; Remacle J
Exp Cell Res; 1994 Jul; 213(1):43-54. PubMed ID: 8020605
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques.
Fukuo K; Inoue T; Morimoto S; Nakahashi T; Yasuda O; Kitano S; Sasada R; Ogihara T
J Clin Invest; 1995 Feb; 95(2):669-76. PubMed ID: 7532188
[TBL] [Abstract][Full Text] [Related]
27. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
28. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
29. Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth.
Ettenson DS; Koo EW; Januzzi JL; Edelman ER
J Cell Physiol; 2000 Jul; 184(1):93-100. PubMed ID: 10825238
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor.
Nakamura Y; Morishita R; Higaki J; Kida I; Aoki M; Moriguchi A; Yamada K; Hayashi S; Yo Y; Nakano H; Matsumoto K; Nakamura T; Ogihara T
J Hypertens; 1996 Sep; 14(9):1067-72. PubMed ID: 8986905
[TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production.
Bamba H; Ota S; Kato A; Matsuzaki F
Biochem Biophys Res Commun; 1998 Apr; 245(2):567-71. PubMed ID: 9571196
[TBL] [Abstract][Full Text] [Related]
32. Cilostazol improves endothelial dysfunction by increasing endothelium-derived hyperpolarizing factor response in mesenteric arteries from Type 2 diabetic rats.
Matsumoto T; Noguchi E; Ishida K; Nakayama N; Kobayashi T; Kamata K
Eur J Pharmacol; 2008 Dec; 599(1-3):102-9. PubMed ID: 18930728
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2 and I2 regulate intercellular adhesion molecule-1 expression in interleukin-1 beta-stimulated human gingival fibroblasts.
Iwasaki K; Noguchi K; Ishikawa I
J Periodontal Res; 1999 Feb; 34(2):97-104. PubMed ID: 10207838
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
Matsumoto-Taniura N; Matsumoto K; Nakamura T
Br J Cancer; 1999 Sep; 81(2):194-202. PubMed ID: 10496342
[TBL] [Abstract][Full Text] [Related]
35. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE
Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789
[TBL] [Abstract][Full Text] [Related]
36. Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.
Hopkins NK; Gorman RR
J Clin Invest; 1981 Feb; 67(2):540-6. PubMed ID: 6257764
[TBL] [Abstract][Full Text] [Related]
37. Cilostazol inhibits high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production.
Omi H; Okayama N; Shimizu M; Fukutomi T; Nakamura A; Imaeda K; Okouchi M; Itoh M
Microvasc Res; 2004 Sep; 68(2):119-25. PubMed ID: 15313121
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
39. Cilostazol in the management of vascular disease.
Dalainas I
Int Angiol; 2007 Mar; 26(1):1-7. PubMed ID: 17353881
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4.
El-Haroun H; Bradbury D; Clayton A; Knox AJ
Circ Res; 2004 Feb; 94(3):353-61. PubMed ID: 14670842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
